AIP
LJPC

Ameritas Investment Partners’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Ameritas Investment Partners’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,535
Closed -$7K – 3379
2021
Q1 		$7K Hold
1,535
– – ﹤0.01% 2969
2020
Q4 		$6K Hold
1,535
– – ﹤0.01% 2961
2020
Q3 		$6K Hold
1,535
– – ﹤0.01% 2959
2020
Q2 		$7K Hold
1,535
– – ﹤0.01% 2907
2020
Q1 		$6K Hold
1,535
– – ﹤0.01% 2798
2019
Q4 		$6K Hold
1,535
– – ﹤0.01% 2896
2019
Q3 		$14K Hold
1,535
– – ﹤0.01% 2597
2019
Q2 		$14K Hold
1,535
– – ﹤0.01% 2673
2019
Q1 		$10K Hold
1,535
– – ﹤0.01% 2719
2018
Q4 		$14K Hold
1,535
– – ﹤0.01% 2539
2018
Q3 		$31K Hold
1,535
– – ﹤0.01% 2281
2018
Q2 		$45K Hold
1,535
– – ﹤0.01% 2068
2018
Q1 		$46K Hold
1,535
– – ﹤0.01% 1967
2017
Q4 		$49K Hold
1,535
– – ﹤0.01% 1947
2017
Q3 		$52K Hold
1,535
– – ﹤0.01% 1883
2017
Q2 		$46K Buy
1,535
+333
+28% +$9.54K ﹤0.01% 1966
2017
Q1 		$36K Buy
+1,202
New +$30.7K ﹤0.01% 2068

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameritas Investment Partners's LJPC Position: Q2 2021 in Review

Ameritas Investment Partners sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 1,535 shares — an estimated $7K sold.

Ameritas Investment Partners first reported a position in LJPC in Q1 2017 and held it in 17 quarters. The position peaked at $52K in Q3 2017. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Ameritas Investment Partners reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,535 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $7K.
  • Ameritas Investment Partners first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 17 quarters.
  • Ameritas Investment Partners's La Jolla Pharmaceutical Company position peaked at $52K in Q3 2017.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.